CCR Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
CCRDie Umsatzerlöse des Unternehmens werden voraussichtlich um 8.6% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 19.9% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 19.3% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.8% betragen.
Wichtige Informationen
19.9%
Wachstumsrate der Gewinne
19.3%
EPS-Wachstumsrate
| Infrastructure Gewinnwachstum | 11.8% |
| Wachstumsrate der Einnahmen | -8.6% |
| Zukünftige Eigenkapitalrendite | 14.8% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 22 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
CCR (BVMF:CCRO3) Is Due To Pay A Dividend Of R$0.1512
Nov 04
Returns Are Gaining Momentum At CCR (BVMF:CCRO3)
Oct 01Market Participants Recognise CCR S.A.'s (BVMF:CCRO3) Earnings
Aug 20Analysts' Revenue Estimates For CCR S.A. (BVMF:CCRO3) Are Surging Higher
Aug 02Is CCR (BVMF:CCRO3) Using Too Much Debt?
Jul 19CCR (BVMF:CCRO3) Might Have The Makings Of A Multi-Bagger
Jun 13There's Reason For Concern Over CCR S.A.'s (BVMF:CCRO3) Price
May 05Is CCR (BVMF:CCRO3) Using Too Much Debt?
Apr 06Slowing Rates Of Return At CCR (BVMF:CCRO3) Leave Little Room For Excitement
Feb 08Risks To Shareholder Returns Are Elevated At These Prices For CCR S.A. (BVMF:CCRO3)
Dec 26CCR (BVMF:CCRO3) Seems To Be Using A Lot Of Debt
Nov 19Here's What To Make Of CCR's (BVMF:CCRO3) Decelerating Rates Of Return
Nov 01Is CCR (BVMF:CCRO3) A Risky Investment?
Aug 14Slowing Rates Of Return At CCR (BVMF:CCRO3) Leave Little Room For Excitement
Jul 26Here's Why CCR (BVMF:CCRO3) Is Weighed Down By Its Debt Load
May 06CCR (BVMF:CCRO3) Is Investing Its Capital With Increasing Efficiency
Apr 13We Think CCR (BVMF:CCRO3) Is Taking Some Risk With Its Debt
Jan 28Under The Bonnet, CCR's (BVMF:CCRO3) Returns Look Impressive
Jan 08Is CCR (BVMF:CCRO3) Using Too Much Debt?
Oct 21Many Would Be Envious Of CCR's (BVMF:CCRO3) Excellent Returns On Capital
Oct 02CCR (BVMF:CCRO3) Takes On Some Risk With Its Use Of Debt
Jul 21Many Would Be Envious Of CCR's (BVMF:CCRO3) Excellent Returns On Capital
Jul 02CCR (BVMF:CCRO3) Is Paying Out Less In Dividends Than Last Year
Apr 07CCR (BVMF:CCRO3) Is Paying Out Less In Dividends Than Last Year
Mar 24Some Investors May Be Worried About CCR's (BVMF:CCRO3) Returns On Capital
Mar 14CCR (BVMF:CCRO3) Has A Pretty Healthy Balance Sheet
Feb 24CCR's (BVMF:CCRO3) Returns On Capital Not Reflecting Well On The Business
Dec 09Is CCR (BVMF:CCRO3) Using Too Much Debt?
Nov 22The Returns On Capital At CCR (BVMF:CCRO3) Don't Inspire Confidence
Sep 09CCR (BVMF:CCRO3) Has A Pretty Healthy Balance Sheet
Aug 19CCR (BVMF:CCRO3) Will Will Want To Turn Around Its Return Trends
Jun 11New Forecasts: Here's What Analysts Think The Future Holds For CCR S.A. (BVMF:CCRO3)
May 25CCR (BVMF:CCRO3) Has A Pretty Healthy Balance Sheet
May 17Does It Make Sense To Buy CCR S.A. (BVMF:CCRO3) For Its Yield?
Apr 29When Should You Buy CCR S.A. (BVMF:CCRO3)?
Apr 06CCR S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 07Has CCR (BVMF:CCRO3) Got What It Takes To Become A Multi-Bagger?
Feb 24CCR (BVMF:CCRO3) Seems To Use Debt Quite Sensibly
Feb 11
Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 17,163 | 2,388 | 3,547 | 4,840 | 3 |
| 12/31/2025 | 16,148 | 1,937 | 1,392 | 4,137 | 5 |
| 12/31/2024 | 16,372 | 1,532 | -1,310 | 3,597 | 5 |
| 9/30/2024 | 21,786 | 1,585 | 1,244 | 7,311 | N/A |
| 6/30/2024 | 20,622 | 1,414 | 1,529 | 6,870 | N/A |
| 3/31/2024 | 19,240 | 1,416 | 1,578 | 6,824 | N/A |
| 12/31/2023 | 18,933 | 1,705 | 1,348 | 6,817 | N/A |
| 9/30/2023 | 16,568 | 934 | 2,120 | 6,889 | N/A |
| 6/30/2023 | 15,794 | 1,289 | 2,522 | 7,338 | N/A |
| 3/31/2023 | 15,305 | 1,310 | 3,018 | 7,009 | N/A |
| 12/31/2022 | 19,182 | 4,133 | 3,468 | 6,486 | N/A |
| 9/30/2022 | 18,446 | 4,217 | -1,423 | 6,005 | N/A |
| 6/30/2022 | 17,637 | 3,794 | -3,583 | 5,142 | N/A |
| 3/31/2022 | 16,799 | 3,459 | -4,868 | 4,700 | N/A |
| 12/31/2021 | 12,244 | 696 | -4,926 | 4,590 | N/A |
| 9/30/2021 | 12,004 | 754 | -242 | 4,163 | N/A |
| 6/30/2021 | 11,542 | 688 | 1,788 | 3,985 | N/A |
| 3/31/2021 | 10,955 | 590 | 2,534 | 3,691 | N/A |
| 12/31/2020 | 9,889 | 191 | 2,908 | 4,152 | N/A |
| 9/30/2020 | 9,995 | 658 | 3,232 | 4,550 | N/A |
| 6/30/2020 | 10,312 | 880 | 3,277 | 4,770 | N/A |
| 3/31/2020 | 10,824 | 1,370 | 3,584 | 5,125 | N/A |
| 12/31/2019 | 10,591 | 1,438 | 3,607 | 4,995 | N/A |
| 9/30/2019 | 10,189 | 739 | 3,150 | 4,573 | N/A |
| 6/30/2019 | 9,886 | 764 | 2,980 | 4,354 | N/A |
| 3/31/2019 | 9,726 | 694 | 1,878 | 3,965 | N/A |
| 12/31/2018 | 9,716 | 783 | 1,368 | 3,686 | N/A |
| 9/30/2018 | 10,532 | 1,419 | 1,254 | 3,782 | N/A |
| 6/30/2018 | 10,568 | 1,526 | N/A | 3,234 | N/A |
| 3/31/2018 | 10,556 | 1,915 | N/A | 3,267 | N/A |
| 12/31/2017 | 10,561 | 1,797 | N/A | 3,340 | N/A |
| 9/30/2017 | 9,839 | 1,638 | N/A | 3,181 | N/A |
| 6/30/2017 | 9,993 | 2,317 | N/A | 4,597 | N/A |
| 3/31/2017 | 10,202 | 1,795 | N/A | 4,548 | N/A |
| 12/31/2016 | 9,996 | 1,714 | N/A | 4,186 | N/A |
| 9/30/2016 | 9,667 | 1,789 | N/A | 3,748 | N/A |
| 6/30/2016 | 9,277 | 885 | N/A | 2,467 | N/A |
| 3/31/2016 | 8,795 | 923 | N/A | 2,435 | N/A |
| 12/31/2015 | 8,479 | 874 | N/A | 2,350 | N/A |
| 9/30/2015 | 8,240 | 1,014 | N/A | 2,279 | N/A |
| 6/30/2015 | 7,979 | 1,113 | N/A | 2,306 | N/A |
| 3/31/2015 | 7,713 | 1,205 | N/A | 2,191 | N/A |
| 12/31/2014 | 7,397 | 1,349 | N/A | 2,188 | N/A |
| 9/30/2014 | 6,954 | 1,271 | N/A | 2,248 | N/A |
| 6/30/2014 | 6,663 | 1,329 | N/A | 2,413 | N/A |
| 3/31/2014 | 6,273 | 1,357 | N/A | 2,434 | N/A |
| 12/31/2013 | 6,017 | 1,351 | N/A | 2,465 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CCRO3Das prognostizierte Gewinnwachstum (19.9% pro Jahr) liegt über der Sparquote (10.4%).
Ertrag vs. Markt: CCRO3Die Erträge des Unternehmens (19.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (12.5% pro Jahr).
Hohe Wachstumserträge: CCRO3Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CCRO3Die Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-8.6% pro Jahr).
Hohe Wachstumseinnahmen: CCRO3Die Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-8.6% pro Jahr).
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CCRO3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.8%).